The effect of enoxaparin with cilostazol for prevention of venous thromboembolism after total knee and hip arthroplasty
Not Applicable
- Conditions
- deep-vein thrombosis
- Registration Number
- JPRN-UMIN000010309
- Lead Sponsor
- Department of orthopedic surgery, Tokyo women's medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
We exclude patients with active bleeding or a high risk of bleeding that contraindicated the use of low-molecular-weight heparin and patients with any contraindication to the use of enoxaparin or cilostazol. Other exclusion criteria include conditions clinically significant compromised renal function, acute endocarditis, heparin induced thrombocytopenia, congestive heart failure, and pregnancy or breast-feeding.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method